`
`
`
`NOTE: This disposition is nonprecedential.
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`WARNER CHILCOTT COMPANY, LLC,
`Plaintiff-Appellee,
`
`v.
`
`LUPIN LTD., LUPIN PHARMACEUTICALS, INC.,
`AMNEAL PHARMACEUTICALS OF NY, LLC, AND
`AMNEAL PHARMACEUTICALS, LLC,
`Defendants-Appellants.
`______________________
`
`2014-1262, -1273
`______________________
`
`Appeals from the United States District Court for the
`District of New Jersey in Nos. 3:11-cv-05048-JAP-TJB
`and 3:12-cv-02928-JAP-TJB, Judge Joel A. Pisano.
`______________________
`
`Decided: October 22, 2014
`______________________
`
`GEORGE F. PAPPAS, Covington & Burling LLP, of
`Washington, DC, argued for plaintiff-appellee. With him
`on the brief were JEFFREY B. ELIKAN, BENJAMIN C. BLOCK,
`ERIC R. SONNENSCHEIN, and JEREMY D. COBB. Of counsel
`was MICHELLE L. MORIN, of Redwood Shores, California.
`
`ROBERT F. GREEN, Leydig, Voit & Mayer, Ltd., of Chi-
`cago, Illinois, argued for defendants-appellants, Lupin
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2002, Pg. 1
`
`
`
`Case: 14-1262 Document: 65-2 Page: 2 Filed: 10/22/2014
`
`Ltd., et al. With him on the brief were CARYN C. BORG-
`BREEN, JESSICA M. TYRUS, and MARC R. WEZOWSKI, of
`Chicago, Illinois, and JAMAICA P. SZELIGA, of Washington,
`DC. On the brief for defendants-appellants Amneal
`Pharmaceuticals of New York, LLC, et al., was PAUL H.
`KOCHANSKI, Lerner, David, Littenberg, Krumholz &
`Mentlik, LLP, of Westfield, New Jersey.
`______________________
`
`Before LOURIE, PLAGER, and WALLACH, Circuit Judges.
`LOURIE, Circuit Judge.
`Lupin Ltd., Lupin Pharmaceuticals, Inc., Amneal
`Pharmaceuticals, LLC, and Amneal Pharmaceuticals of
`New York, LLC (collectively, the “Defendants”) appeal
`from the decision of the United States District Court for
`the District of New Jersey, which held that claims 1–9
`(“the asserted claims”) of U.S. Patent 7,704,984 (the “’984
`patent”) were not invalid for obviousness under 35 U.S.C.
`§ 103(a) (2006). See Warner Chilcott Co. v. Lupin Ltd.,
`No. 3:11-CV-05048, 2014 WL 202659 (D.N.J. Jan. 17,
`2014).
`Warner Chilcott Co., LLC (“Warner”) owns the ’984
`patent, which is directed to a method of contraception and
`covers the administration of Warner’s oral contraceptive
`drug product, Lo Loestrin® Fe (“Lo Loestrin”). The De-
`fendants submitted Abbreviated New Drug Application
`filings to the U.S. Food and Drug Administration for
`approval to engage in the commercial manufacture, use,
`or sale of generic versions of Lo Loestrin. Warner then
`brought actions against the Defendants for infringement
`of the asserted claims under 35 U.S.C. § 271(e)(2)(A) and
`the actions were consolidated into the case now before us
`on appeal.
`Before the district court, the Defendants stipulated to
`infringement of all of the asserted claims, but challenged
`the validity of those claims on the ground of obviousness.
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2002, Pg. 2
`
`
`
`Case: 14-1262 Document: 65-2 Page: 3 Filed: 10/22/2014
`
`Warner Chilcott, 2014 WL 202659, at *1–2. The district
`court held a bench trial from October 7, 2013 through
`October 17, 2013 on the issue of obviousness. Id. at *1.
`In a detailed opinion issued on January 17, 2014, the
`district court held that the Defendants failed to prove by
`clear and convincing evidence that the asserted claims of
`the ’984 patent would have been obvious. Id. at *11, *23.
`The court then entered final judgment of infringement in
`favor of Warner. See Warner Chilcott Co. v. Lupin Ltd.,
`No. 3:11-CV-05048 (D.N.J. Jan. 17, 2014), ECF No. 135.
`The Defendants timely appealed, and we have jurisdiction
`pursuant to 28 U.S.C. § 1295(a)(1).
`Having considered all of the Defendants’ arguments
`on appeal and found them unpersuasive, we conclude that
`on the basis of and for the reasons stated in the district
`court’s thorough opinion none of the asserted claims of the
`’984 patent was shown to be invalid for obviousness. We
`therefore affirm the judgment of the district court.
`AFFIRMED
`
`Mylan v. Warner Chilcott IPR2015-00682
`WC Ex. 2002, Pg. 3
`
`